Solvent Accessibility of Native and Hydrolyzed Human Complement Protein 3 Analyzed by Hydrogen/Deuterium Exchange and Mass Spectrometry 1

Complement protein C3 is a 187-kDa (1641-aa) protein that plays a key role in complement activation and immune responses. Its hydrolyzed form, C3(H2O), is responsible for the initiation of the activation of alternative complement pathway. Previous analyses using mAbs, anilinonaphthalenesulfonate dyes, and functional studies have suggested that C3 is conformationally different from C3(H2O). We have used amide hydrogen/deuterium exchange and MALDI-TOF mass spectrometry to identify and localize structural differences between native C3 and C3(H2O). Both proteins were incubated in D2O for varying amounts of time, digested with pepsin, and then subjected to mass-spectrometric analysis. Of 111 C3 peptides identified in the MALDI-TOF analysis, 31 had well-resolved isotopic mass envelopes in both C3 and C3(H2O) spectra. Following the conversion of native C3 to C3(H2O), 17 of these 31 peptides exhibited a change in deuterium incorporation, suggesting a conformational change in these regions. Among the identified peptides, hydrogen/deuterium exchange data were obtained for peptides 944–967, 1211–1228, 1211–1231, 1259–1270, 1259–1273, 1295–1318, and 1319–1330, which span the factor H binding site on C3d and factor I cleavage sites, and peptides 1034–1048, 1049–1058, 1069–1080, 1130–1143, 1130–1145, 1211–1228, 1211–1231, 1259–1270, and 1259–1273, spanning 30% of the C3d region of C3. Our results suggest that hydrolysis may produce a looser (more open) structure in the C3d region, in which some of the changes affect the conversion of helical segments into coil segments facilitating interactions with factors I and H. This study represents the first detailed study mapping the regions of C3 involved in conformational transition when hydrolyzed to C3(H2O).

[1]  B. Nilsson,et al.  Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression. , 1992, The Biochemical journal.

[2]  K. Whaley,et al.  Modulation of the alternative complement pathways by beta 1 H globulin , 1976, The Journal of experimental medicine.

[3]  J. Mandell,et al.  Measurement of amide hydrogen exchange by MALDI-TOF mass spectrometry. , 1998, Analytical chemistry.

[4]  Robert B Sim,et al.  Pattern of degradation of human complement fragment, C3b , 1981, FEBS letters.

[5]  Dimitrios Morikis,et al.  Binding Kinetics, Structure-Activity Relationship, and Biotransformation of the Complement Inhibitor Compstatin1 , 2000, The Journal of Immunology.

[6]  R. Harrison,et al.  Structural characterization of factor I mediated cleavage of the third component of complement. , 1982, Biochemistry.

[7]  M. Pangburn,et al.  A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement. , 1987, Journal of immunological methods.

[8]  Robert B Sim,et al.  Interactions between human complement components factor H, factor I and C3b. , 1997, The Biochemical journal.

[9]  B. Nilsson,et al.  Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides. , 1990, The Biochemical journal.

[10]  B. Nagar,et al.  X-ray crystal structure of C3d: a C3 fragment and ligand for complement receptor 2. , 1998, Science.

[11]  H. Gresham,et al.  Large scale isolation of functionally active components of the human complement system. , 1981, The Journal of biological chemistry.

[12]  A. Eerenberg,et al.  Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies. , 1988, Journal of immunology.

[13]  N. Cooper,et al.  The structure and function of the third component of human complement--I. The nature and extent of conformational changes accompanying C3 activation. , 1981, Molecular immunology.

[14]  N. Kallenbach,et al.  Hydrogen exchange and structural dynamics of proteins and nucleic acids , 1983, Quarterly Reviews of Biophysics.

[15]  C. Woodward,et al.  Hydrogen exchange and the dynamic structure of proteins , 1982, Molecular and Cellular Biochemistry.

[16]  Zhongqi Zhang,et al.  Probing the non-covalent structure of proteins by amide hydrogen exchange and mass spectrometry. , 1997, Journal of mass spectrometry : JMS.

[17]  D. Isenman Conformational changes accompanying proteolytic cleavage of human complement protein C3b by the regulatory enzyme factor I and its cofactor H. Spectroscopic and enzymological studies. , 1983, The Journal of biological chemistry.

[18]  M. Deinzer,et al.  Hydrogen/deuterium exchange and mass spectrometric analysis of a protein containing multiple disulfide bonds: Solution structure of recombinant macrophage colony stimulating factor‐beta (rhM‐CSFβ) , 2002 .

[19]  J. Prahl,et al.  Third component of human complement: purification from plasma and physicochemical characterization. , 1976, Biochemistry.

[20]  J. Lambris,et al.  Dissection of CR1, factor H, membrane cofactor protein, and factor B binding and functional sites in the third complement component. , 1996, Journal of immunology.

[21]  P. Wright,et al.  Hydrogen exchange in the carbon monoxide complex of soybean leghemoglobin. , 1996, European journal of biochemistry.

[22]  John D Lambris,et al.  Molecular aspects of C3 interactions and structural/functional analysis of C3 from different species. , 1990, Current topics in microbiology and immunology.

[23]  M. Pangburn,et al.  Detection of a neoantigen on human C3bi and C3d by monoclonal antibody. , 1985, Journal of immunology.

[24]  R. Schreiber,et al.  Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3 , 1981, The Journal of experimental medicine.

[25]  M. Pangburn,et al.  Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies , 1982, The Journal of experimental medicine.

[26]  K. Resing,et al.  Modeling deuterium exchange behavior of ERK2 using pepsin mapping to probe secondary structure , 1999, Journal of the American Society for Mass Spectrometry.

[27]  Zhongqi Zhang,et al.  Determination of amide hydrogen exchange by mass spectrometry: A new tool for protein structure elucidation , 1993, Protein science : a publication of the Protein Society.

[28]  B. Nilsson,et al.  Structural and functional analysis of C3 using monoclonal antibodies. , 1990, Current topics in microbiology and immunology.

[29]  M. Müller,et al.  Changes in antigenic properties of human C3 upon activation and conversion by trypsin. , 1974, Journal of immunology.

[30]  Virgil L. Woods,et al.  Protein structure change studied by hydrogen-deuterium exchange, functional labeling, and mass spectrometry , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[31]  R. Discipio Ultrastructures and interactions of complement factors H and I. , 1992, Journal of immunology.

[32]  B. Nilsson,et al.  Production of mouse monoclonal antibodies that detect distinct neoantigenic epitopes on bound C3b and iC3b but not on the corresponding soluble fragments. , 1987, Molecular immunology.

[33]  T. Fujita,et al.  Characterization of three monoclonal antibodies against C3 with selective specificities. , 1987, Immunology.

[34]  B. Nilsson,et al.  Analogous antigenic alterations elicited in C3 by physiologic binding and by denaturation in the presence of sodium dodecylsulfate. , 1982, Journal of immunology.

[35]  John D Lambris,et al.  Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Lambris,et al.  A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. , 1988, The Journal of biological chemistry.

[37]  M. Pangburn,et al.  Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement , 1980, The Journal of experimental medicine.

[38]  John D Lambris,et al.  Release of endogenous C3b inactivator from lymphocytes in response to triggering membrane receptors for beta 1H globulin , 1980, The Journal of experimental medicine.

[39]  John D Lambris,et al.  The multifunctional role of C3, the third component of complement. , 1988, Immunology today.

[40]  John D Lambris,et al.  Structure and biology of complement protein C3, a connecting link between innate and acquired immunity , 2001, Immunological reviews.

[41]  J. Lambris,et al.  Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 Fragments for Factors B and H, complement receptors , and bovine conglutinin , 1983, The Journal of experimental medicine.

[42]  E. Goldsmith,et al.  Changes in protein conformational mobility upon activation of extracellular regulated protein kinase-2 as detected by hydrogen exchange. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Robert B Sim,et al.  Molecular modelling of human complement component C3 and its fragments by solution scattering. , 1986, European journal of biochemistry.

[44]  R. Schreiber,et al.  Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution , 1977, The Journal of experimental medicine.